4D Molecular Therapeutics FDMT

$ 8.64 -13.69%

Quarterly report 2026-Q1
added 05-07-2026

4D Molecular Therapeutics EV/EBITDA Ratio 2011-2026 | FDMT

Annual EV/EBITDA Ratio 4D Molecular Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
-3.21	-0.77	-8.07	-4.98	-3.46	-4.59	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
-0.77	-8.07	-4.18